James T. Glover, SVP, Operations and CFO at ANADYS PHARMACEUTICALS INC (ANDS), bought 1,000 shares at $2.17 ($2K) on 2007-08-15, disclosed to the SEC on 2007-08-16.
Open-market purchase of $2k ANDS by SVP, Operations and CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ANDS | BUY | 2007-11-19 | $4K | — | Filing → |
| ANDS | BUY | 2007-11-13 | $11K | — | Filing → |
| ANDS | BUY | 2007-03-02 | $14K | — | Filing → |